Add Company
Join Now

Glyscend Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Glyscend's estimated annual revenue is currently $2.8M per year.(i)
  • Glyscend's estimated revenue per employee is $310,000

Employee Data

  • Glyscend has 9 Employees.(i)
  • Glyscend grew their employee count by -40% last year.

Glyscend's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CMO and Head Research and DevelopmentReveal Email/Phone
3
SVP, Clinical Operations and PharmacovigilanceReveal Email/Phone
4
Associate Director, Clinical OperationsReveal Email/Phone
5
Sr. Director Clinical and Translational ScienceReveal Email/Phone
6
Founder, Chief Medical Officer and Head R&DReveal Email/Phone
7
Senior Director Operations & StrategyReveal Email/Phone
8
Senior Project Manager ConsultantReveal Email/Phone
9
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M20%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M130%N/AN/A
#8
$7.4M4721%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Glyscend?

Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$2.8M

Revenue (est)

-40%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M90%N/A
#2
$0.9M9-10%N/A
#3
$1.4M9-18%N/A
#4
$0.9M9-10%N/A
#5
$4M9-31%N/A